Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 386

1.

GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study.

Dalgaard F, Pieper K, Verheugt F, Camm AJ, Fox KA, Kakkar AK, Pallisgaard JL, Rasmussen PV, Weert HV, Lindhardt TB, Torp-Pedersen C, Gislason GH, Ruwald MH, Harskamp RE.

BMJ Open. 2019 Nov 11;9(11):e033283. doi: 10.1136/bmjopen-2019-033283.

2.

Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.

Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP.

Am Heart J. 2019 Nov 8;219:21-30. doi: 10.1016/j.ahj.2019.10.008. [Epub ahead of print]

PMID:
31710841
3.

Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles.

Petrova VN, Sawatsky B, Han AX, Laksono BM, Walz L, Parker E, Pieper K, Anderson CA, de Vries RD, Lanzavecchia A, Kellam P, von Messling V, de Swart RL, Russell CA.

Sci Immunol. 2019 Nov 1;4(41). pii: eaay6125. doi: 10.1126/sciimmunol.aay6125.

PMID:
31672862
4.

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS.

Nauck MA, McGuire DK, Pieper KS, Lokhnygina Y, Strandberg TE, Riefflin A, Delibasi T, Peterson ED, White HD, Scott R, Holman RR.

Cardiovasc Diabetol. 2019 Sep 3;18(1):116. doi: 10.1186/s12933-019-0921-2.

5.

Efforts by the journal to promote perspectives of equity, diversity, and inclusion and address disparities.

Baskin PK, Pieper KM, Gross RA.

Neurology. 2019 Sep 17;93(12):521-522. doi: 10.1212/WNL.0000000000008021. Epub 2019 Jul 31. No abstract available.

PMID:
31366721
6.

Understanding lead in water and avoidance strategies: a United States perspective for informed decision-making.

Pieper KJ, Katner A, Kriss R, Tang M, Edwards MA.

J Water Health. 2019 Aug;17(4):540-555. doi: 10.2166/wh.2019.272.

PMID:
31313993
7.

Corrosion of upstream metal plumbing components impact downstream PEX pipe surface deposits and degradation.

Huang X, Pieper KJ, Cooper HK, Diaz-Amaya S, Zemlyanov DY, Whelton AJ.

Chemosphere. 2019 Dec;236:124329. doi: 10.1016/j.chemosphere.2019.07.060. Epub 2019 Jul 10.

PMID:
31310967
8.

Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II.

Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Am Heart J. 2019 Jul;213:81-90. doi: 10.1016/j.ahj.2019.04.007. Epub 2019 Apr 24.

PMID:
31129441
9.

Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF.

Haas S, Camm AJ, Bassand JP, Angchaisuksiri P, Cools F, Corbalan R, Gibbs H, Jacobson B, Koretsune Y, Mantovani LG, Misselwitz F, Panchenko E, Ragy HI, Stepinska J, Turpie AG, Sawhney JP, Steffel J, Lim TW, Pieper KS, Virdone S, Verheugt FW, Kakkar AK; GARFIELD-AF Investigators.

Am Heart J. 2019 Jul;213:35-46. doi: 10.1016/j.ahj.2019.03.013. Epub 2019 Apr 11.

10.

Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.

Corbalan R, Bassand JP, Illingworth L, Ambrosio G, Camm AJ, Fitzmaurice DA, Fox KAA, Goldhaber SZ, Goto S, Haas S, Kayani G, Mantovani LG, Misselwitz F, Pieper KS, Turpie AGG, Verheugt FWA, Kakkar AK; GARFIELD-AF Investigators.

JAMA Cardiol. 2019 Jun 1;4(6):526-548. doi: 10.1001/jamacardio.2018.4729.

PMID:
31066873
11.

Toothbrushing behavior in children - an observational study of toothbrushing performance in 12 year olds.

Deinzer R, Cordes O, Weber J, Hassebrauck L, Weik U, Krämer N, Pieper K, Margraf-Stiksrud J.

BMC Oral Health. 2019 Apr 29;19(1):68. doi: 10.1186/s12903-019-0755-z.

12.

Peripheral blood metabolite profiles associated with new onset atrial fibrillation.

Harskamp RE, Granger TM, Clare RM, White KR, Lopes RD, Pieper KS, Granger CB, Newgard CB, Shah SH, Newby LK.

Am Heart J. 2019 May;211:54-59. doi: 10.1016/j.ahj.2019.01.010. Epub 2019 Feb 14. French.

PMID:
30889527
13.

Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry.

Jerjes-Sanchez C, Corbalan R, Barretto ACP, Luciardi HL, Allu J, Illingworth L, Pieper KS, Kayani G; GARFIELD-AF Investigators.

Clin Cardiol. 2019 May;42(5):553-560. doi: 10.1002/clc.23176. Epub 2019 Apr 9.

14.

Correlation of avian bornavirus-specific antibodies and viral ribonucleic acid shedding with neurological signs and feather-damaging behaviour in psittacine birds.

Fluck A, Enderlein D, Piepenbring A, Heffels-Redmann U, Herzog S, Pieper K, Herden C, Lierz M.

Vet Rec. 2019 Apr 13;184(15):476. doi: 10.1136/vr.104860. Epub 2019 Feb 12.

PMID:
30755457
15.

Sequential Cu-Catalyzed Four- and Five-Component Syntheses of Luminescent 3-Triazolylquinoxalines.

Merkt FK, Pieper K, Klopotowski M, Janiak C, Müller TJJ.

Chemistry. 2019 Jul 17;25(40):9447-9455. doi: 10.1002/chem.201900277. Epub 2019 Apr 9.

PMID:
30740794
16.

Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry.

Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Pieper KS, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators.

Thromb Haemost. 2019 Feb;119(2):319-327. doi: 10.1055/s-0038-1676611. Epub 2018 Dec 28.

PMID:
30593086
17.

Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation.

Bassand JP, Virdone S, Goldhaber SZ, Camm AJ, Fitzmaurice DA, Fox KAA, Goto S, Haas S, Hacke W, Kayani G, Mantovani LG, Misselwitz F, Pieper KS, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK.

Circulation. 2019 Feb 5;139(6):787-798. doi: 10.1161/CIRCULATIONAHA.118.035012.

PMID:
30586740
18.

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials.

Fanaroff AC, Clare R, Pieper KS, Mahaffey KW, Melloni C, Green JB, Alexander JH, Jones WS, Harrison RW, Mehta RH, Povsic TJ, Moreira HG, Al-Khatib SM, Roe MT, Kong DF, Mathews R, Tricoci P, Holman RR, Wallentin L, Held C, Califf RM, Alexander KP, Lopes RD.

Circulation. 2019 Feb 12;139(7):863-873. doi: 10.1161/CIRCULATIONAHA.118.037202.

PMID:
30586739
19.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, Vanajakshamma V, Meena R, Vijayaraghavan G, Chawla K, Allu J, Pieper KS, John Camm A, Kakkar AK; GARFIELD-AF Investigators.

Indian Heart J. 2018 Nov - Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12.

20.

Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan - Insights From GARFIELD-AF.

Koretsune Y, Etoh T, Katsuda Y, Suetsugu T, Kumeda K, Sakuma I, Eshima K, Shibuya M, Ando SI, Yokota N, Goto S, Pieper KS, Allu J, Kakkar AK; GARFIELD-AF Investigators.

Circ J. 2018 Dec 25;83(1):67-74. doi: 10.1253/circj.CJ-18-0655. Epub 2018 Dec 4.

21.

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.

Essien UR, Holmes DN, Jackson LR 2nd, Fonarow GC, Mahaffey KW, Reiffel JA, Steinberg BA, Allen LA, Chan PS, Freeman JV, Blanco RG, Pieper KS, Piccini JP, Peterson ED, Singer DE.

JAMA Cardiol. 2018 Dec 1;3(12):1174-1182. doi: 10.1001/jamacardio.2018.3945.

PMID:
30484833
22.

Reply to letter by Bamford et al. regarding the article: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.

Piccini JP, Garg J, Hellkamp A, Pieper KS, Patel MR.

Eur Heart J. 2019 May 14;40(19):1568. doi: 10.1093/eurheartj/ehy743. No abstract available.

PMID:
30476238
23.

Pharmacokinetics of low-dose and high-dose buprenorphine in cats after rectal administration of different formulations.

Schroers M, Meyer-Lindenberg A, Reese S, Dobenecker B, Pieper K.

J Feline Med Surg. 2019 Oct;21(10):938-943. doi: 10.1177/1098612X18810933. Epub 2018 Nov 14.

PMID:
30427272
24.

A fast-evolving X-linked duplicate of importin-α2 is overexpressed in sex-ratio drive in Drosophila neotestacea.

Pieper KE, Unckless RL, Dyer KA.

Mol Ecol. 2018 Dec;27(24):5165-5179. doi: 10.1111/mec.14928. Epub 2018 Dec 10.

PMID:
30411843
25.

Impact of Road Salt on Drinking Water Quality and Infrastructure Corrosion in Private Wells.

Pieper KJ, Tang M, Jones CN, Weiss S, Greene A, Mohsin H, Parks J, Edwards MA.

Environ Sci Technol. 2018 Dec 18;52(24):14078-14087. doi: 10.1021/acs.est.8b04709. Epub 2018 Nov 28.

PMID:
30407803
26.

B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.

Inohara T, Kim S, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Heart. 2019 Mar;105(5):370-377. doi: 10.1136/heartjnl-2018-313642. Epub 2018 Sep 18.

PMID:
30228248
27.

Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry).

Thind M, Holmes DN, Badri M, Pieper KS, Singh A, Blanco RG, Steinberg BA, Fonarow GC, Gersh BJ, Mahaffey KW, Peterson ED, Reiffel JA, Piccini JP, Kowey PR; ORBIT-AF Investigators and Patients.

Am J Cardiol. 2018 Nov 15;122(10):1677-1683. doi: 10.1016/j.amjcard.2018.07.045. Epub 2018 Aug 20.

PMID:
30227964
28.

Isolating and Incorporating Light-Harvesting Antennas from Diatom Cyclotella Meneghiniana in Liposomes with Thylakoid Lipids.

Pieper K, Gundermann K, Dietzel L.

J Vis Exp. 2018 Aug 28;(138). doi: 10.3791/58017.

PMID:
30222147
29.

Association between a New Sugar Index and Caries Experience: Results of a Cross-Sectional Field Study.

Pieper K, Winter J, Heinzel-Gutenbrunner M, Margraf-Stiksrud J.

Caries Res. 2019;53(2):160-167. doi: 10.1159/000486102. Epub 2018 Aug 8.

30.

Effectiveness of Prevailing Flush Guidelines to Prevent Exposure to Lead in Tap Water.

Katner A, Pieper K, Brown K, Lin HY, Parks J, Wang X, Hu CY, Masters S, Mielke H, Edwards M.

Int J Environ Res Public Health. 2018 Jul 20;15(7). pii: E1537. doi: 10.3390/ijerph15071537.

31.

Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).

Valgimigli M, Garcia-Garcia HM, Vrijens B, Vranckx P, McFadden EP, Costa F, Pieper K, Vock DM, Zhang M, Van Es GA, Tricoci P, Baber U, Steg G, Montalescot G, Angiolillo DJ, Serruys PW, Farb A, Windecker S, Kastrati A, Colombo A, Feres F, Jüni P, Stone GW, Bhatt DL, Mehran R, Tijssen JGP.

Eur Heart J. 2019 Jul 1;40(25):2070-2085. doi: 10.1093/eurheartj/ehy377.

PMID:
29992264
32.

Evaluating Water Lead Levels During the Flint Water Crisis.

Pieper KJ, Martin R, Tang M, Walters L, Parks J, Roy S, Devine C, Edwards MA.

Environ Sci Technol. 2018 Aug 7;52(15):8124-8132. doi: 10.1021/acs.est.8b00791. Epub 2018 Jul 11.

33.

Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.

Inohara T, Pieper K, Wojdyla DM, Patel MR, Jones WS, Tricoci P, Mahaffey KW, James SK, Alexander JH, Lopes RD, Wallentin L, Ohman EM, Roe MT, Vemulapalli S.

Am Heart J. 2018 Jul;201:25-32. doi: 10.1016/j.ahj.2018.03.013. Epub 2018 Mar 28.

PMID:
29910052
34.

Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction.

Rymer JA, Tempelhof MW, Clare RM, Pieper KS, Granger CB, Van de Werf F, Moliterno DJ, Harrington RA, White HD, Armstrong PW, Lopes RD, Mahaffey KW, Newby LK.

Am Heart J. 2018 Jul;201:103-110. doi: 10.1016/j.ahj.2018.04.010. Epub 2018 Apr 20.

35.

Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.

Le Heuzey JY, Bassand JP, Berneau JB, Cozzolino P, D'Angiolella L, Doucet B, Mantovani LG, Martelet M, Mouallem J, Muller JJ, Pieper K; GARFIELD-AF Investigators.

Arch Cardiovasc Dis. 2018 Dec;111(12):749-757. doi: 10.1016/j.acvd.2018.03.012. Epub 2018 Jun 1.

PMID:
29861295
36.

Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis.

Scirica BM, Bansilal S, Davoudi F, Armstrong PW, Clare RM, Schulte PJ, Pieper KS, Becker RC, James SK, Storey RF, Steg PG, Held C, Himmelmann A, Mahaffey KW, Wallentin L, Cannon CP; PLATO Steering Committee and Investigators.

Am Heart J. 2018 Aug;202:54-60. doi: 10.1016/j.ahj.2018.04.020. Epub 2018 May 7.

PMID:
29859968
37.

Risk Score to Predict Need for Intensive Care in Initially Hemodynamically Stable Adults With Non-ST-Segment-Elevation Myocardial Infarction.

Fanaroff AC, Chen AY, Thomas LE, Pieper KS, Garratt KN, Peterson ED, Newby LK, de Lemos JA, Kosiborod MN, Amsterdam EA, Wang TY.

J Am Heart Assoc. 2018 May 25;7(11). pii: e008894. doi: 10.1161/JAHA.118.008894.

38.

Implementation and evaluation of an interdisciplinary preventive program to prevent early childhood caries.

Winter J, Bartsch B, Schütz C, Jablonski-Momeni A, Pieper K.

Clin Oral Investig. 2019 Jan;23(1):187-197. doi: 10.1007/s00784-018-2426-x. Epub 2018 Mar 26.

PMID:
29582152
39.

Elevated Lead in Water of Private Wells Poses Health Risks: Case Study in Macon County, North Carolina.

Pieper KJ, Nystrom VE, Parks J, Jennings K, Faircloth H, Morgan JB, Bruckner J, Edwards MA.

Environ Sci Technol. 2018 Apr 3;52(7):4350-4357. doi: 10.1021/acs.est.7b05812. Epub 2018 Mar 14.

PMID:
29536726
40.

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

Steinberg BA, Shrader P, Pieper K, Thomas L, Allen LA, Ansell J, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli GV, Reiffel JA, Singer DE, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) II Investigators.

J Am Heart Assoc. 2018 Feb 16;7(4). pii: e007633. doi: 10.1161/JAHA.117.007633.

41.

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial.

Sherwood MW, Lopes RD, Sun JL, Liaw D, Harrington RA, Wallentin L, Laskowitz DT, James SK, Goodman SG, Darius H, Lewis BS, Gibson CM, Pieper KS, Alexander JH.

Am Heart J. 2018 Mar;197:1-8. doi: 10.1016/j.ahj.2017.09.020. Epub 2017 Oct 24.

PMID:
29447769
42.

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.

Bassand JP, Accetta G, Al Mahmeed W, Corbalan R, Eikelboom J, Fitzmaurice DA, Fox KAA, Gao H, Goldhaber SZ, Goto S, Haas S, Kayani G, Pieper K, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK; GARFIELD-AF Investigators.

PLoS One. 2018 Jan 25;13(1):e0191592. doi: 10.1371/journal.pone.0191592. eCollection 2018.

43.

Long-term effect of intensive prevention on dental health of primary school children by socioeconomic status.

Winter J, Jablonski-Momeni A, Ladda A, Pieper K.

Clin Oral Investig. 2018 Jul;22(6):2241-2249. doi: 10.1007/s00784-017-2318-5. Epub 2017 Dec 29.

PMID:
29288402
44.

Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.

Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D, Bassand JP, Camm AJ, Cools F, Eikelboom J, Kayani G, Lim TW, Misselwitz F, Pieper KS, van Eickels M, Kakkar AK; GARFIELD-AF Investigators.

Eur Heart J. 2018 Feb 7;39(6):464-473. doi: 10.1093/eurheartj/ehx730.

PMID:
29281086
45.

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.

Fox KAA, Lucas JE, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Oto A, Mantovani LG, Misselwitz F, Piccini JP, Turpie AGG, Verheugt FWA, Kakkar AK; GARFIELD-AF Investigators.

BMJ Open. 2017 Dec 21;7(12):e017157. doi: 10.1136/bmjopen-2017-017157.

46.

International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.

Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ, Ezekowitz MD, Fonarow GC, Gersh BJ, Goldhaber S, Haas S, Hacke W, Kowey PR, Ansell J, Mahaffey KW, Naccarelli G, Reiffel JA, Turpie A, Verheugt F, Piccini JP, Kakkar A, Peterson ED, Fox KAA; GARFIELD-AF; ORBIT-AF Investigators.

Am Heart J. 2017 Dec;194:132-140. doi: 10.1016/j.ahj.2017.08.011. Epub 2017 Aug 24.

47.

Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study.

Inohara T, Shrader P, Pieper K, Blanco RG, Thomas L, Singer DE, Freeman JV, Allen LA, Fonarow GC, Gersh B, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Steinberg BA, Peterson ED, Piccini JP.

JAMA Cardiol. 2018 Jan 1;3(1):54-63. doi: 10.1001/jamacardio.2017.4665.

48.

Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Fox KAA, Accetta G, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Kayani G, Kakkar AK; GARFIELD-AF Investigators.

Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):27-35. doi: 10.1093/ehjqcco/qcx030.

PMID:
28950344
49.

Public antibodies to malaria antigens generated by two LAIR1 insertion modalities.

Pieper K, Tan J, Piccoli L, Foglierini M, Barbieri S, Chen Y, Silacci-Fregni C, Wolf T, Jarrossay D, Anderle M, Abdi A, Ndungu FM, Doumbo OK, Traore B, Tran TM, Jongo S, Zenklusen I, Crompton PD, Daubenberger C, Bull PC, Sallusto F, Lanzavecchia A.

Nature. 2017 Aug 31;548(7669):597-601. doi: 10.1038/nature23670. Epub 2017 Aug 23.

50.

Disease understanding in patients newly diagnosed with atrial fibrillation.

Kaufman BG, Kim S, Pieper K, Allen LA, Gersh BJ, Naccarelli GV, Ezekowitz MD, Fonarow GC, Mahaffey KW, Singer DE, Chan PS, Freeman JV, Ansell J, Kowey PR, Rieffel JA, Piccini J, Peterson E, O'Brien EC.

Heart. 2018 Mar;104(6):494-501. doi: 10.1136/heartjnl-2017-311800. Epub 2017 Aug 8.

Supplemental Content

Loading ...
Support Center